Skip to content
healthcare.dev

Darzalex IV

NDC 57894-505, Daratumumab, injection, solution, concentrate, from Janssen Biotech, Inc..

Product NDC
57894-505
Status
Listed
Labeler
Janssen Biotech, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761036
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-505 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARATUMUMAB100 mg/5mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; CD38-directed Antibody Interactions [MoA]; CD38-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
57894-505-05578940505051 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE
57894-505-20578940505201 VIAL, SINGLE-DOSE in 1 BOX (57894-505-20) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a4d0efe9-5e54-467e-9eb4-56fa7d53b60b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=57894-505

Use it

Look up 57894-505 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-505 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-505. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.